Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
LegalZoom.com
LZ
$1.35B
| $1.56M | ﹤0.01% |
96,838
+1,916
| +2% | +$40.7K |
|
2777
Nkarta
NKTX
$150M
| $1.55M | ﹤0.01% |
101,188
+3,115
| +3% | +$53.4K |
|
2778
Identive
INVE
$63.4M
| $1.55M | ﹤0.01% |
55,112
+1,544
| +3% | +$33.9K |
|
2779
MeiraGTx Holdings
MGTX
$1.09B
| $1.55M | ﹤0.01% |
65,107
+2,414
| +4% | +$46.2K |
|
|
NBP
2780
NovaBridge Biosciences American Depositary Shares
NBP
$185M
| $1.53M | ﹤0.01% |
32,356
-2,504
| -7% | -$150K |
|
2781
Cognyte Software
CGNT
$659M
| $1.52M | ﹤0.01% |
97,143
+12,956
| +15% | +$262K |
|
2782
Farmers National Banc Corp
FMNB
$939M
| $1.51M | ﹤0.01% |
81,428
+17,023
| +26% | +$303K |
|
|
BRY
2783
DELISTED
Berry Corp
BRY
| $1.5M | ﹤0.01% |
178,646
+4,173
| +2% | +$36.8K |
|
|
KZR
2784
DELISTED
Kezar Life Sciences
KZR
| $1.5M | ﹤0.01% |
8,940
+429
| +5% | +$48.4K |
|
2785
Oscar Health
OSCR
$9.41B
| $1.48M | ﹤0.01% |
188,703
+8,439
| +5% | +$106K |
|
2786
Harvard Bioscience
HBIO
$27.5M
| $1.48M | ﹤0.01% |
20,987
| – | – |
|
2787
Root
ROOT
$857M
| $1.48M | ﹤0.01% |
26,485
+3,276
| +14% | +$256K |
|
2788
StoneCo
STNE
$2.77B
| $1.48M | ﹤0.01% |
87,592
+38,518
| +78% | +$977K |
|
|
GRTS
2789
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $1.47M | ﹤0.01% |
113,987
+11,617
| +11% | +$129K |
|
2790
Utah Medical Products
UTMD
$225M
| $1.46M | ﹤0.01% |
14,558
| – | – |
|
|
RBNC
2791
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $1.46M | ﹤0.01% |
40,986
+1,897
| +5% | +$64.5K |
|
|
ACBI
2792
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $1.46M | ﹤0.01% |
50,545
+1,156
| +2% | +$32.7K |
|
2793
Boston Omaha
BOC
$428M
| $1.45M | ﹤0.01% |
50,347
+6,232
| +14% | +$203K |
|
|
PSTX
2794
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.44M | ﹤0.01% |
211,761
+2,826
| +1% | +$19.3K |
|
2795
ZipRecruiter
ZIP
$321M
| $1.43M | ﹤0.01% |
57,444
+1,082
| +2% | +$29.7K |
|
|
VTYX
2796
DELISTED
Ventyx Biosciences
VTYX
| $1.42M | ﹤0.01% |
+71,321
| New | +$1.35M |
|
|
SBDS
2797
DELISTED
Solo Brands Inc
SBDS
| $1.41M | ﹤0.01% |
+2,248
| New | +$1.54M |
|
2798
Business First Bancshares
BFST
$1.04B
| $1.4M | ﹤0.01% |
49,313
+1,258
| +3% | +$34K |
|
|
RVI
2799
DELISTED
Retail Value Inc. Common Shares
RVI
| $1.39M | ﹤0.01% |
443,726
-2,178,876
| -83% | -$6.19M |
|
|
GOLD
2800
Gold.com Inc
GOLD
$1.2B
| $1.38M | ﹤0.01% |
45,032
+918
| +2% | +$30.7K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.